Exactly. Everyone focused on one headline while the real story is RYET planting a flag in a $1T healthcare AI market. This is just the start.
#teenageee
$AXP $QCOM
The bigger picture behind the latest $RYET news is much larger than one Malaysia agreement
AI in healthcare is becoming a global industry. Current market estimates put the sector at roughly $56B in 2026, with forecasts reaching around $1 TRILLION by 2034.
That is the market backdrop for RYET latest move.
Ruanyun announced a definitive agreement involving Cogni AI and BioNexus Gene Lab in Malaysia, giving its AI technology a path into healthcare rather than keeping it limited to education and enterprise applications.
The structure is interesting too: an exclusive license framework of up to 20 years, 10% royalty economics on qualifying technology receipts, and 560K BGLC shares at closing.
For me, this is what makes the news important.
RYET is not suddenly becoming a healthcare giant. It is testing whether Cogni AI can be licensed into a completely different industry and international market while that industry itself is experiencing massive AI adoption.
Education was the starting point.
Enterprise AI expanded the story.
Now healthcare adds another potential use case.
If Cogni AI can continue moving across industries and markets, that becomes a much more interesting business model than relying on one product or one sector.
Malaysia may be only the first healthcare test, but it puts RYET directly in front of one of the fastest-growing global technology trends.
RYET now has another path for commercializing Cogni AI. RYET is also set to receive 560K BGLC shares at closing. That commercial angle is what makes the news interesting.
$SONY #Tejran#BBNaija
BREAKING: $RYET just added a completely new business lane in Malaysia.
The company announced an agreement with BioNexus Gene Lab that brings Cogni AI into healthcare, moving the technology beyond education and enterprise use cases
$RYET the Malaysia healthcare deal with BioNexus gives Cogni AI a new commercial path, with up to 20 years of exclusivity, 10% royalty economics and 560K BGLC shares at closing
New market. New vertical. More attention on the story.
$RYET is moving into Malaysian healthcare 🇲🇾
The Cogni AI deal with BioNexus brings up to 20 years of exclusivity, 10% royalty economics and 560K BGLC shares at closing.
This is the $RYET update I wanted to highlight again
Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, versus only about $0.37M in H1 FY2026
And that six-month figure already exceeds the company’s $7.48M FY2026 full-year revenue
That is a major change in operating scale
Preliminary and unaudited, but the revenue growth is now the main story to watch
https://t.co/aCBt2Z2jsH
Catch the market catalysts that matter
Daily Market Memo tracks breaking company news, unusual activity and fresh market developments so traders can quickly see what deserves deeper research
Free market research: https://t.co/ki8JcAdH72
$RYET H1 FY27 prelim $9.3M-$9.5M against ~$0.37M in H1 FY26, and it tops the $7.48M full FY26. Six months beating a whole year is the real headline. 👀
#Tejran
$ARM $BAC
$RYET just changed the scale of the story
Preliminary H1 FY2027 revenue: $9.3M-$9.5M
H1 FY2026: ~$0.37M
FY2026 full year: $7.48M
Six months could now beat the entire prior fiscal year
That’s the number traders should be watching
$RYET $9.3M-$9.5M in H1 FY2027 vs $0.37M in H1 FY2026, and it already tops the $7.48M full-year FY2026. Smart Campus alone $5.0M-$5.2M.
#bb28
$QCOM $PATH
$RYET is up 5.39% to $0.8648 while today’s revenue news keeps getting attention
The company expects preliminary H1 FY2027 revenue of $9.3M-$9.5M, already above FY2026 full-year revenue of $7.48M
$RYET just dropped a major revenue update
Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M
For context:
H1 FY2026: ~$0.37M
H1 FY2025: $4.11M
FY2026 full year: $7.48M
Just 6 months could now exceed the entire previous fiscal year
Preliminary, unaudited
https://t.co/f45qLeWj8I
As the Trump administration deliberates how to fight historically high gas and diesel prices, a growing number of US states are taking matters into their own hands. https://t.co/lHgjM6V2rU
$RYET just raised the bar
Preliminary H1 FY2027 revenue is expected at $9.3M-$9.5M, already above FY2026 full-year revenue of $7.48M
That’s the kind of growth shift traders notice fast
$5.72M from Smart Campus and an ~$880K YeeZo deal tells me adoption is already there. Formind just ties the pieces together. $RYET
#nolimitt
$AMZN $COIN
$RYET is becoming more than an edtech story
Smart Campus generated $5.72M, YeeZo landed an ~$880K deal, and Formind now connects YeeZo, Cogni AI, Smart Campus and HanLink across multiple markets
Execution is the next catalyst
Don't miss the opportunity.
🚨BREAKING: $RYET JUST LAUNCHED FORMIND GROUP
The new global platform ties together RYET’s AI + education strategy across YeeZo, Cogni AI, Smart Campus and HanLink
Recent numbers:
$7.48M FY2026 revenue
$5.72M Smart Campus revenue
~$880K YeeZo contract
10 AIGC labs + 610 workstations
RYET is also trading around $0.86, above its 20-day SMA near $0.83.
Now traders are watching whether the Formind rollout can bring more contracts, more recognized revenue and stronger volume.
$880K YEEZO CONTRACT
$RYET deployment covers 10 AIGC labs + 610 workstations.
With FY2026 revenue at $7.48M, this is a meaningful commercial win. Now traders are watching whether YeeZo can scale into more deployments and recurring revenue.
https://t.co/fFVZzhkzDa
$RYET reported FY2026 revenue of $7.48M, up 11.9% YoY
The company is expanding beyond traditional edtech into Smart Campus services, AI document intelligence through Cogni AI, and AI content workflows through YeeZo
One recent YeeZo deployment contract was valued at approximately $880K
Watching how these new business lines translate into future reported revenue